What is Advanced CTS?
Advanced CTS Corp. (ACTS) operates as a specialized FDA-registered drug distribution wholesaler, providing a sophisticated suite of services tailored for the complexities of clinical research. Headquartered in New Jersey, the firm functions as a vital intermediary in the drug development lifecycle, offering comprehensive drug depot services, global import and export capabilities, and the strategic sourcing of comparator and reference-listed drugs. By bridging the gap between manufacturers and clinical study sites across the US, Europe, and Japan, ACTS delivers a transparent, one-stop solution that mitigates supply chain risks and accelerates the pace of medical innovation. Their market position is defined by high-compliance standards and a robust logistical framework that supports the rigorous demands of modern clinical trials.
How much funding has Advanced CTS raised?
Advanced CTS has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Advanced CTS
PPP
Public-Private Partnership
What's next for Advanced CTS?
With the successful acquisition of this late-stage capital, Advanced CTS is strategically positioned to scale its global footprint and optimize its distribution network. The firm is expected to prioritize the integration of advanced tracking technologies and the expansion of its cold-chain storage facilities to accommodate the growing complexity of biologics and specialized therapeutics. As the clinical trial landscape becomes increasingly globalized, ACTS will likely focus on deepening its regulatory expertise in emerging markets, thereby reinforcing its value proposition as an indispensable partner for pharmaceutical sponsors navigating the intricacies of international drug sourcing and distribution.
See full Advanced CTS company page
